Nested N-terminal megalin fragments induce high-titer autoantibody and attenuated Heymann nephritis

Journal of the American Society of Nephrology

Volumn 17, Issue 7, 2006, Pages 1979-1985

  Tramontane, Alfonso ^a   Knight, Thomas ^a   Vizzuso, Domenica ^a   Makker, Sudesh P ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; AUTOANTIBODY; COMPLEMENT COMPONENT C3; COMPLEMENT MEMBRANE ATTACK COMPLEX; IMMUNOGLOBULIN CLASS; IMMUNOGLOBULIN G1; MEGALIN;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY TITER; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL PROLIFERATION; CLONE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GLOMERULUS; HEYMANN NEPHRITIS; IMMUNOPATHOGENESIS; INSECT CELL; LIGAND BINDING; LYMPH NODE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN GLYCOSYLATION; PROTEIN PROCESSING; PROTEIN STRUCTURE; PROTEINURIA; RAT; STAINING;

EID: 33745827421     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1681/ASN.2005101144     Document Type: Article

References (35)

1. Raychowdhury R, Niles J, McCluskey R, Smith J: Autoimmune target in Heymann nephritis is a glycoprotein with homology to the LDL receptor. Science 244: 1163-1165, 1989
2. Huang J, Makker S: Role of receptor-associated 39-45kDa protein in active Heymann nephritis. Kidney Int 47: 432-441, 1995
3. Makker S, Singh A: Characterization of the antigen (gp600) of Heymann nephritis. Lab Invest 50: 287-293, 1984
4. Makker S, Singh A: Biochemical analysis of nephritogenic rat kidney tubular membrane fraction (Fx1A). Fed Proc 41: 1159, 1982
5. Kerjaschki D, Farquhar MG: The pathogenic antigen of Heymann nephritis is a membrane glycoprotein of the renal proximal tubule brush border. Proc Natl Acad Sci U S A 79: 5557-5581, 1982
6. Van Leer EH, Ronco P, Verroust P, van der Wal AM, Hoedemaeker PJ, De Heer E: Epitope specificity of anti-gp330 autoantibodies determines the development of proteinuria in active Heymann nephritis. Am J Pathol 142: 821-829, 1993
7. Couser WG, Steinmuller DR, Stilmant MM, Salant DJ, Lowenstein LM: Experimental glomerulonephritis in the isolated perfused rat kidney. J Clin Invest 62: 1275-1287, 1978
8. Orlando RA, Kerjaschki D, Farquhar MG: Megalin (gp330) possesses an antigenic epitope capable of inducing passive Heymann nephritis independent of the nephritogenic epitope in receptor-associated protein. J Am Soc Nephrol 6: 61-67, 1995
9. Saito A, Pietromonaco S, Loo AK, Farquhar MG: Complete cloning and sequencing of rat gp330/"megalin," a distinctive member of the low density lipoprotein receptor gene family. Proc Natl Acad Sci U S A 91: 9725-9729, 1994
10. Luca ME, De Geus B, Sahali D, Bruijn JA, Verroust P, De Heer E: Isolation of cDNAs encoding immunogenic regions of gp330, the autoantigen involved in Heymann nephritis. Clin Exp Immunol 104: 312-317, 1996
11. Raychowdhury R, Zheng G, Brown D, McCluskey RT: Induction of Heymann nephritis with a gp330/megalin fusion protein. Am J Pathol 148: 1613-1623, 1996
12. Saito A, Yamazaki H, Rader K, Nakatani A, Ullrich R, Kerjaschki D, Orlando RA, Farquhar MG: Mapping rat megalin: The second cluster of ligand binding repeats contains a 46-amino acid pathogenic epitope involved in the formation of immune deposits in Heymann nephritis. Proc Natl Acad Sci U S A 93: 8601-8605, 1996
13. Tramontano A, Makker SP: Conformation and glycosylation of a megalin fragment correlate with nephritogenicity in Heymann nephritis. J Immunol 172: 2367-2373, 2004
14. Christensen EI, Birn H: Megalin and cubilin: Multifunctional endocytic receptors. Nat Rev Mol Cell Biol 3: 256-266, 2002
15. Yamazaki H, Ullrich R, Exner M, Saito A, Orlando RA, Kerjaschki D, Farquhar MG: All four putative ligand-binding domains in megalin contain pathogenic epitopes capable of inducing passive Heymann nephritis. J Am Soc Nephrol 9: 1638-1644, 1998
16. Oleinikov AV, Feliz BJ, Makker SP: A small N-terminal 60-kD fragment of gp600 (megalin), the major autoantigen of active Heymann nephritis, can induce a full-blown disease. J Am Soc Nephrol 11: 57-64, 2000
17. Zheng G, Bachinsky DR, Stamenkovic I, Strickland DK, Brown D, Andres G, McCluskey RT: Organ distribution in rats of two members of the low-density lipoprotein receptor gene family, gp330 and LRP/alpha 2MR, and the receptor-associated protein (RAP). J Histochem Cytochem 42: 531-542, 1994
18. Ziak M, Meier M, Roth J: Megalin in normal tissues and carcinoma cells carries oligo/poly alpha2,8 deaminoneuraminic acid as a unique posttranslational modification. Glycoconj J 16: 185-188, 1999
19. Ziak M, Kerjaschki D, Farquhar MG, Roth J: Identification of megalin as the sole rat kidney sialoglycoprotein containing poly alpha2,8 deaminoneuraminic acid. J Am Soc Nephrol 10: 203-209, 1999
20. Kanalas JJ, Makker SP: A possible ligand of serum origin for the kidney autoantigen of Heymann nephritis. J Immunol 141: 4152-4157, 1988
21. Makker SP: Analysis of glomeruli-eluted Gp330 autoantibodies and of Gp330 antigen of Heymann nephritis. J Immunol 151: 6500-6508, 1993
22. Makker S, Widstrom R, Huang J: Transcription and translation of gp600 and receptor-associated protein (RAP) in active Heymann nephritis. Am J Pathol 146: 1481-1487, 1995
23. Medgyesi GA, Fust G, Gergely J, Bazin H: Classes and subclasses of rat immunoglobulins: Interaction with the complement system and with staphylococcal protein A. Mol Immunol 15: 125-129, 1978
24. Shimizu S, Sugiyama N, Masutani K, Sadanaga A, Miyazaki Y, Inoue Y, Akahoshi M, Katafuchi R, Hirakata H, Harada M, Hamano S, Nakashima H, Yoshida H: Membranous glomerulonephritis development with Th2-type immune deviations in MRL/lpr mice deficient for IL-27 receptor (WSX-1). J Immunol 175: 7185-7192, 2005
25. Leenaerts PL, Hall BM, Van Damme BJ, Daha MR, Vanrenterghem YF: Active Heymann nephritis in complement component C6 deficient rats. Kidney Int 47: 1604-1614, 1995
26. Cybulsky AV, Rennke HG, Feintzeig ID, Salant DJ: Complement-induced glomerular epithelial cell injury. Role of the membrane attack complex in rat membranous nephropathy. J Clin Invest 77: 1096-1107, 1986
27. Salant DJ, Quigg RJ, Cybulsky AV: Heymann nephritis: Mechanisms of renal injury. Kidney Int 35: 976-984, 1989
28. Schiller B, He C, Salant DJ, Lim A, Alexander JJ, Quigg RJ: Inhibition of complement regulation is key to the pathogenesis of active Heymann nephritis. J Exp Med 188: 1353-1358, 1998
29. Orlando RA, Exner M, Czekay RP, Yamazaki H, Saito A, Ullrich R, Kerjaschkl D, Farquhar MG: Identification of the second cluster of ligand-binding repeats in megalin as a site for receptor-ligand interactions. Proc Natl Acad Sci U S A 94: 2368-2373, 1997
30. Kerjaschki D, Exner M, Ullrich R, Susani M, Curtiss LK, Witztum JL, Farquhar MG, Orlando RA: Pathogenic antibodies inhibit the binding of apolipoproteins to megalin/gp330 in passive Heymann nephritis. J Clin Invest 100: 2303-2309, 1997
31. Ziak M, Roth J: Expression of oligo/polyalpha2,8-linked deaminoneuraminic acid and megalin during kidney development and maturation: Mutually exclusive distribution with polyalpha2,8-linked N-acetylneuraminic acid of N-CAM. Histochem Cell Biol 112: 169-178, 1999
32. Morelle W, Haslam SM, Ziak M, Roth J, Morris HR, Dell A: Characterization of the N-linked oligosaccharides of megalin (gp330) from rat kidney. Glycobiology 10: 295-304, 2000
33. Chui D, Sellakumar G, Green R, Sutton-Smith M, McQuistan T, Marek K, Morris H, Dell A, Marth J: Genetic remodeling of protein glycosylation in vivo induces autoimmune disease. Proc Natl Acad Sci U S A 98: 1142-1147, 2001
34. Doyle HA, Mamula MJ: Post-translational protein modifications in antigen recognition and autoimmunity. Trends Immunol 22: 443-449, 2001
35. Doyle HA, Mamula MJ: Posttranslational protein modifications: New flavors in the menu of autoantigens. Curr Opin Rheumatol 14: 244-249, 2002